Cardiovascular Diseases Clinical Trial
To determine whether the degree of carotid artery atherosclerosis, as measured by B-mode ultrasound, predicts the development of myocardial infarction, stroke, and all-cause mortality in patients with angiographically defined coronary status. Also, to quantify the rate of progression of carotid artery disease and to evaluate the risk factors associated with progression of carotid atherosclerosis.
BACKGROUND:
Although angiographic evidence of coronary atherosclerosis is one of the best predictors of
clinical events, non-invasive imaging of this arterial bed is not yet possible. The
availability of non-invasive methods for imaging the carotid arteries, and the
intra-individual similarity of extent of disease in the coronary and carotid arteries
provides rationale for this study that assesses the usefulness of B-mode ultrascan
evaluation of extracranial carotid artery atherosclerosis as an independent predictor of
clinical sequelae such as fatal and non-fatal myocardial infarction and stroke.
DESIGN NARRATIVE:
Pilot data from an ongoing case-comparison study of risk factors for coronary and carotid
atherosclerosis as defined by angiography and B-mode ultrasound provided a background for
this project. Patients from the pilot study were used in this study. Beginning in 1986,
traditional risk factors such as lipids, lipoproteins, blood pressure, diabetes, and smoking
were measured as were non-traditional risk factors such as apolipoproteins and genetic
markers. The cohort was followed for 3.5 to 8.5 years for incidence of clinical events.
Multivariate techniques were used to relate disease or risk factor status to all-cause
mortality, fatal and non-fatal myocardial infarction, and fatal and non-fatal stroke. The
same subjects were re-evaluated periodically by B-mode for extent of carotid
atherosclerosis. A fifty percent random sample of patients positive for both cerebrovascular
disease and coronary artery disease and a fifty percent random sample of patients negative
for both cerebrovascular disease and coronary artery disease had repeat B-mode measurements
at 2.5 years. All patients surviving at the end of five years had repeat B-mode scans.
The study was renewed in 1996 through April 1999 to conduct a longitudinal study testing the
following hypotheses: 1.) Incidence of cardiovascular events (bypass surgery, angioplasty,
fatal and non-fatal myocardial infarction, and stroke and endarterectomy) in men and women
with extensive carotid wall thickening (CWT) at baseline exceeds that of those with less
extensive baseline carotid wall thickening; the relation of carotid wall thickening to
outcome is independent of coronary artery disease and/or coronary artery disease risk
factors; and, 2.) carotid wall thickening progresses more rapidly in males and females with
coronary artery disease and/or coronary artery disease risk factors than in coronary artery
disease/risk factor free controls.
The investigators intend to: 1) follow-up a cohort of 670 individuals with defined coronary
anatomy, extent of carotid wall thickening, and coronary artery disease risk factors over
5-10 years for fatal and non-fatal cardiovascular events. Coronary artery disease, carotid
wall thickening, and coronary artery disease risk factor status at accession will be related
to outcome; and, 2.) In a separate (new) cohort of 280 volunteers with and without coronary
artery disease they will evaluate carotid wall thickening yearly for three years, and use
multivariable analysis to relate accession status to progression rate. Availability of a
unique sample of patients largely already characterized for coronary status (at
angiography), coronary artery disease risk factors, and carotid wall thickening, and
development of B-mode methods for quantifying carotid wall thickening and biostatistical
approaches for quantifying progression of carotid wall thickening over a short time span
(three years) provide opportunity for this project. Recent pilot data support its
feasibility.
The study completion date listed in this record was obtained from the "End Date" entered in
the Protocol Registration and Results System (PRS) record.
;
N/A
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|